Protean

Produces recombinant proteins and enzymes and develops pathogen diagnostics for research and diagnostics organizations

Dobrá Voda u Českých Budějovic, CzechiaFounded 2008protean.bioWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-11-08

About Protean

Protean develops pathogen diagnostics and produces artificial and native recombinant proteins, including enzymes, antibodies, antigens and cytokines. Its services include contract research and tick-borne infection analysis.

Customers include biotechnology and diagnostics companies, vaccine developers, and research organizations. Products are manufactured in certified environments under ISO 9001 and ISO 13485 standards.

Founded in 2008, Protean is based in Dobrá Voda u Českých Budějovic, Czech Republic. It serves customers internationally.

Product: Recombinant proteins and enzymes, pathogen diagnostics, contract research, and tick-borne infection analysis.

Public contracts

Contracts Protean signed since 1 Nov 2024, from the Slovak and Czech public contract registers. Values as published; amendments are not counted.

Customers

3 contracts with 2 buyers · 1.0M CZK

ContractsValue
Státní veterinární ústav Jihlava2970k CZK
Revmatologický ústav169k CZK

Open public tenders for Protean →

Latest contracts

  • 30 Sep 2026 for Státní veterinární ústav Jihlava · Smlouva o nájmu - nebytové prostory · 150k CZK register
  • 16 Mar 2026 for Státní veterinární ústav Jihlava · Smlouva o nájmu - nebytové prostory, laboratoře · 820k CZK register
  • 11 Jun 2025 for Revmatologický ústav · Dodávky: Lab.chemikálie · 69k CZK register

Jobs at Protean

No open positions listed right now.

Leadership

More biotech & pharma companies

  • PSI (Photon Systems Instruments)

    Plant phenotyping, photosynthesis and controlled-environment instruments for plant science and algae research labs
    Drásov, CzechiaBiotech & pharmaFounded 19948 open jobs
  • ReForm Therapeutics CZ

    Needle-free emergency drug formulations, starting with an intranasal epinephrine product for anaphylaxis
    Brno, CzechiaBiotech & pharmaFounded 2022
    Young company
  • ROCHE

    Czech affiliate of the Roche pharma and diagnostics group, supplying medicines and diagnostic products to Czech healthcare professionals
    Praha, CzechiaBiotech & pharmaFounded 1992
  • RosenPharma

    Pharmaceutical manufacturer making supplements, creams and tablets for consumers in the Czech Republic, selling also via its own e-shop
    Veverské Knínice, CzechiaBiotech & pharmaFounded 2003
  • Salimex CZ

    Wholesale distribution of medicines and medical supplies in Czechia, plus leased warehouse space for pharma partners
    Brno, CzechiaBiotech & pharmaFounded 2020
    New on Evolc
  • Sanofi

    Develops medicines and vaccines for patients and public health worldwide
    Praha, CzechiaBiotech & pharmaFounded 1991

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Analytics

  • Google Analytics 4High confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • Google Tag ManagerMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • Google Universal AnalyticsMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Backend

  • PHPMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Frontend frameworks

  • BootstrapHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • jQueryHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Hosting

Marketing & advertising

  • Google AdsHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.